Pune, India, February,2019/MRFR Press Release/- Market Research Future has published a half-cooked research report on the Global Surgical Chips Market.
The surgical chips market is growing pervasively mainly due to the burgeoning healthcare sector. The market is booming and expected to gain prominence over the forecast period. Acknowledging this growth of the market, Market Research Future (MRFR) in its recently published study report asserts that the global surgical chips market is poised to expand enormously by 2027 registering a steady CAGR throughout the assessment period (2017 and 2027).
Additionally, factors such as the advancements in technology and increasing automation in the healthcare sector are substantiating market growth. These technological advancements are leading to widening the applications of these chips for various tasks that have been directed towards reducing the costs of products.
On the flip side, prohibiting cost of these surgical chips, risks associated with the surgeries, and the skepticism toward technology are some of the factors impeding the growth of the market. However, recent developments in surgical chips such as high integration of advanced artificial intelligence (AI)technology along with the spreading awareness towards the advantages and usages of surgical chips for patient tracking, medical records management, and healthcare quality control are expected to support the growth of the surgical chips market throughout the review period.
Browse Complete Report @ https://www.marketresearchfuture.com/reports/surgical-chips-market-1310
Global Surgical Chips Market – Segmentations
The MRFR analysis has been segmented into four key dynamics for enhanced understanding.
By Types : DNA Chips, Brain Chips, Lab Chips, Protein Chips, and Tissue Chip among others.
By Application : Cancer Diagnosis and Treatment, Gene Expression, SNP Genotyping, Genomics, and Clinical Diagnostics among others.
By End-users : Hospitals, Research Centers, and Clinics among others.
By Regions : Asia Pacific, North America, Europe, and the Rest-of-the-World.
Global Surgical Chips Market – Geographical Analysis
The North American region, heading with the well-established healthcare sector, accounts for the leading market for the surgical clips. Factors such as the increasing demand for chip-based technology and devices and the growing prevalence of lifestyle-borne and chronic diseases positively impact the growth of the regional market.
The Europe surgical chips market led by the increasing healthcare expenditures and availability of advanced treatment facilities, accounts for the second-largest market, globally. Factors such as the increasing government initiatives & funding for research activities, rising demand for technology-based medical devices, and advancements in the treatment procedures options are fostering the growth of the regional market.
The Asia Pacific surgical chips market backed by the faster adoption of healthcare technology is rapidly emerging as a promising market. Moreover, factors such as favorable government policies to improve the quality of healthcare alongside the favorable reimbursement and insurance policies are fostering the growth of the APAC surgical chips market.
Similarly, other major factors such as the growing adoption of advanced medical devices and developing healthcare infrastructure are fuelling the growth of the regional market.
Global Surgical Chips Market – Competitive Landscape
Moderately competitive, the surgical chips market appears to be consolidated due to the presence of a limited number of key players. Well-established players incorporate strategic initiatives such as partnership, acquisition, collaboration, expansion, and technology launch in order to gain a competitive edge and to maintain positions in this market. These players substantially invest in R&D and clinical trials to develop effective surgical chips.
Focused on improving their market performance and expansion, vendors providing this technology are acquiring promising companies in the fast-growing markets. They employ a continuous improvement strategy to analyze and update the software by implementing improvements, launching new technologies that can meet the changing requirements of the healthcare Industry.
They strive to develop a well-established infrastructure that can allow seamless implementation of advanced technologies. The growth and immense revenue generation opportunities that this market is currently demonstrating, is, in turn, attracting several new entrants. Nevertheless, those newly entered players find it challenging to survive in the market with the rapid introduction of new technologies.
Key players leading the global surgical chips market include Agilent Technologies, Inc. (US), PerkinElmer, Inc. (US), Abbott Laboratories (US), Illumina, Inc. (US), GE Healthcare (UK), Fluidigm Corporation (US), Cepheid (US), Roche Diagnostics (Switzerland), Bio-Rad Laboratories Inc. (US), and Thermo Fisher Scientific, Inc. (US) among others.
August 02, 2018 – The Indian Institute of Technology (IIT) Kharagpur is a public engineering institution established by the government of India announced its plans to develop coin-sized biological chips to develop advanced battery-free implantable medical devices for treatment of brain, nerve, muscle or spinal cord disorders that are untreatable by using standard medical practices.
November 03, 2018 – Olympus America Inc. (US), a leading global technology player designing and manufacturing medical and surgical products announced receiving the Surgical Products’ 2018 Excellence in Surgical Products (ESP) Award.
Company’s 3D imaging comes with a chip-on-tip and dual lens design combined with FlexDex technology that simplifies suturing in difficult-to-reach areas by precisely translating the surgeon’s hand, wrist and arm movements.